These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 12660411)

  • 1. Biology of congenital obstructive nephropathy.
    Liapis H
    Nephron Exp Nephrol; 2003; 93(3):e87-91. PubMed ID: 12660411
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathophysiology of obstructive nephropathy in the newborn.
    Chevalier RL
    Semin Nephrol; 1998 Nov; 18(6):585-93. PubMed ID: 9819149
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Obstructive nephropathy: towards biomarker discovery and gene therapy.
    Chevalier RL
    Nat Clin Pract Nephrol; 2006 Mar; 2(3):157-68. PubMed ID: 16932414
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renal tubulointerstitial injury from ureteral obstruction in the neonatal rat is attenuated by IGF-1.
    Chevalier RL; Goyal S; Kim A; Chang AY; Landau D; LeRoith D
    Kidney Int; 2000 Mar; 57(3):882-90. PubMed ID: 10720941
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Obstructive nephropathy: insights from genetically engineered animals.
    Bascands JL; Schanstra JP
    Kidney Int; 2005 Sep; 68(3):925-37. PubMed ID: 16105023
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biochemical-molecular markers in unilateral ureteral obstruction.
    Manucha W
    Biocell; 2007; 31(1):1-12. PubMed ID: 17665634
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biomarkers of congenital obstructive nephropathy: past, present and future.
    Chevalier RL
    J Urol; 2004 Sep; 172(3):852-7. PubMed ID: 15310982
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Experimental models of fetal obstructive nephropathy.
    Matsell DG; Tarantal AF
    Pediatr Nephrol; 2002 Jul; 17(7):470-6. PubMed ID: 12172756
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Congenital ureteropelvic junction obstruction: human disease and animal models.
    Klein J; Gonzalez J; Miravete M; Caubet C; Chaaya R; Decramer S; Bandin F; Bascands JL; Buffin-Meyer B; Schanstra JP
    Int J Exp Pathol; 2011 Jun; 92(3):168-92. PubMed ID: 20681980
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Opposite role of CD44-standard and CD44-variant-3 in tubular injury and development of renal fibrosis during chronic obstructive nephropathy.
    Rampanelli E; Rouschop KM; Claessen N; Teske GJ; Pals ST; Leemans JC; Florquin S
    Kidney Int; 2014 Sep; 86(3):558-69. PubMed ID: 24717295
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased expression of TGF-beta1 but not of its receptors contributes to human obstructive nephropathy.
    Kaneto H; Ohtani H; Fukuzaki A; Ishidoya S; Takeda A; Ogata Y; Nagura H; Orikasa S
    Kidney Int; 1999 Dec; 56(6):2137-46. PubMed ID: 10594789
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatocyte growth factor gene therapy retards the progression of chronic obstructive nephropathy.
    Gao X; Mae H; Ayabe N; Takai T; Oshima K; Hattori M; Ueki T; Fujimoto J; Tanizawa T
    Kidney Int; 2002 Oct; 62(4):1238-48. PubMed ID: 12234294
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of PAX2 gene expression by siRNA (polyethylenimine) in experimental model of obstructive nephropathy.
    Li L; Wu Y; Wang C; Zhang W
    Ren Fail; 2012; 34(10):1288-96. PubMed ID: 23078635
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recovery from release of ureteral obstruction in the rat: relationship to nephrogenesis.
    Chevalier RL; Thornhill BA; Chang AY; Cachat F; Lackey A
    Kidney Int; 2002 Jun; 61(6):2033-43. PubMed ID: 12028444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Congenital ureteropelvic junction obstruction: physiopathology, decoupling of tout court pelvic dilatation-obstruction semantic connection, biomarkers to predict renal damage evolution.
    Alberti C
    Eur Rev Med Pharmacol Sci; 2012 Feb; 16(2):213-9. PubMed ID: 22428472
    [TBL] [Abstract][Full Text] [Related]  

  • 16. WT-1 mRNA expression is modulated by nitric oxide availability and Hsp70 interaction after neonatal unilateral ureteral obstruction.
    Mazzei L; García IM; Cacciamani V; Benardón ME; Manucha W
    Biocell; 2010 Dec; 34(3):121-32. PubMed ID: 21443142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The kininogen gene family in obstructive uropathy.
    El-Dahr SS
    Semin Nephrol; 1998 Nov; 18(6):633-40. PubMed ID: 9819154
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular and cellular pathophysiology of obstructive nephropathy.
    Chevalier RL
    Pediatr Nephrol; 1999 Sep; 13(7):612-9. PubMed ID: 10460514
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PAX2 is reactivated in urinary tract obstruction and partially protects collecting duct cells from programmed cell death.
    Cohen T; Loutochin O; Amin M; Capolicchio JP; Goodyer P; Jednak R
    Am J Physiol Renal Physiol; 2007 Apr; 292(4):F1267-73. PubMed ID: 17164400
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatocyte growth factor suppresses interstitial fibrosis in a mouse model of obstructive nephropathy.
    Mizuno S; Matsumoto K; Nakamura T
    Kidney Int; 2001 Apr; 59(4):1304-14. PubMed ID: 11260391
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.